ACT Advisors’s P3 Health Partners PIII Stock Holding History

ACT Advisors’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-229	Closed	-$1.88K	–	67
2025 Q1	$1.88K	Buy	+229	New	+$2.26K	﹤0.01%	57

Other funds holding PIII

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACT Advisors's PIII Position: Q2 2025 in Review

ACT Advisors sold out of P3 Health Partners (PIII) in Q2 2025, closing a stake of 229 shares — an estimated $1.88K sold.

ACT Advisors first reported a position in PIII in Q1 2025 and held it in 1 quarter. The position peaked at $1.88K in Q1 2025. 16 funds tracked by Wall St. Rank hold PIII as of Q2 2025.

ACT Advisors reported no remaining P3 Health Partners position as of Q2 2025 after selling out during the quarter.
ACT Advisors sold 229 P3 Health Partners shares in Q2 2025, an estimated $1.88K.
ACT Advisors first reported a position in P3 Health Partners in Q1 2025 and held it in 1 quarter.
ACT Advisors's P3 Health Partners position peaked at $1.88K in Q1 2025.
16 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2025.

Based on ACT Advisors's 13F filing for Q2 2025, filed 15 Jul 2025.